A Promising Drug With a Flaw was the name of an article published in the New York Times this past week.
'Pradaxa has been linked to more than 500 deaths in the United States, demonstrating that in our current civilization it is fine to make a fortune killing people. Though a chorus of complaints has risen from doctors, victims’ families and others in the medical community, the FDA is not worried that its approval process was not sufficiently rigorous.
“Pradaxa was identified as the primary suspect in 542 patient deaths reported to the FDA in 2011, and was linked to more reports of injury or death than any of the more than 800 drugs regularly monitored by the Institute for Safe Medication Practices, a nonprofit based in Pennsylvania that monitors medicine safety,” reported the Times.'
Read more...
Read more...
Related Post:
Widget by [ Iptek-4u ]
